MATERIALS AND METHODS
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Kidney cancer - statistics.Cancer. Net. 2020; (Available at:) (Accessed March 3, 2020): 1
- Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases.Am J Surg Pathol. 2002; 26: 281-291https://doi.org/10.1097/00000478-200203000-00001
- Frequency, incidence, and survival outcomes of clear cell renal cell carcinoma in the United States from 1973 to 2014: A SEER-based analysis.Medicine (Baltimore). 2019; 98: e16684https://doi.org/10.1097/MD.0000000000016684
- Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.Cancer Med. 2016; 5: 200-208https://doi.org/10.1002/cam4.578
- Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival.J Urol. 2008; 179: 1704-1708https://doi.org/10.1016/j.juro.2008.01.027
- Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.Cancer. 2016; 122: 2988-2995https://doi.org/10.1002/cncr.30146
- Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities.Cancer Causes Control. 2020; 31: 263-272https://doi.org/10.1007/s10552-020-01270-8
- Effect of African American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma.Cancer Epidemiol. 2018; 54: 112-118https://doi.org/10.1016/j.canep.2018.04.006
- Race affects access to nephrectomy but not survival in renal cell carcinoma.BJU Int. 2009; 103: 889-893https://doi.org/10.1111/j.1464-410X.2008.08119.x
- Racial bias in health care and health: challenges and opportunities.JAMA. 2015; 314: 555-556https://doi.org/10.1001/jama.2015.9260
- Racial disparities in renal cell carcinoma: a single-payer healthcare experience.Cancer Med. 2016; 5: 2101-2108https://doi.org/10.1002/cam4.755
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2015), National Cancer Institute, DCCPS, Surveillance Research Program, released April 2019, based on the November 2018 submission.
- Outcome of renal tumors in young adults.J Urol. 2006; 175: 1240-1243https://doi.org/10.1016/S0022-5347(05)00696-8
- Incidence of hypertension and educational attainment: the NHANES I epidemiologic follow-up study. First National Health and Nutrition Examination Survey.Am J Epidemiol. 2000; 152: 272-278https://doi.org/10.1093/aje/152.3.272
- Intensive blood-pressure control in hypertensive chronic kidney disease.N Engl J Med. 2010; 363: 918-929https://doi.org/10.1056/NEJMoa0910975
- Disparities in treatment and outcome for renal cell cancer among older black and white patients.J Clin Oncol. 2007; 25: 3589-3595https://doi.org/10.1200/JCO.2006.10.0156
- The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.J Am Soc Nephrol. 2010; 21: 1422-1426https://doi.org/10.1681/ASN.2010070730
- The Surveillance, Epidemiology, and End Results (SEER) program and pathology: toward strengthening the critical relationship.Am J Surg Pathol. 2016; 40: e94-e102https://doi.org/10.1097/PAS.0000000000000749